CEO Mark Capone talks about Myriad’s 25-year history and our pioneering work in the molecular diagnostics industry, as well as his vision for the future. “We’ve helped 2 million patients over the last 25 years, but we’re just getting started.”

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.